Study examines impact of CPOE systems in five Mass. community hospitals

NewsGuard 100/100 Score

New research finds a drop in preventable adverse drug events following implementation of computer order entry systems at community hospitals

Despite a national mandate to implement electronic health records and computer order entry systems (CPOE) by 2014, only approximately 30 percent of hospitals nationwide have done so and around 40 percent of hospitals in the state of Massachusetts have made this transition. New research from Brigham and Women's Hospital cd the impact of a vendor-developed CPOE in five community hospitals in Massachusetts and found that these CPOE systems are effective at reducing drug-related injury and harm. This research is published online in the Journal of General Internal Medicine.

The majority of studies that evaluate CPOE systems have been performed in academic settings with systems that have been developed internally. While these studies have demonstrated significant reductions in the rates of preventable adverse drug events (ADE), there has been no research into the effectiveness of vendor CPOE systems in a community hospital setting.

"We knew from prior research that there was potential to significantly reduce preventable ADEs at community hospitals through CPOE," said Dr. David Bates, Senior Vice President for Quality and Safety at Brigham and Women's Hospital and senior author on the study. "Our research demonstrates that this is true. We observed a 34 percent reduction in preventable ADEs overall in the community hospital setting following the implementation of a vendor CPOE system."

Researchers evaluated the impact of CPOE systems on the frequency of adverse drug events (ADE) in five community hospitals in Massachusetts between January 2005 and September 2011. Each hospital independently selected and implemented a vendor CPOE system with decision support capabilities. They looked at the incidence of preventable ADEs and the rate of potential ADEs and ADEs overall.

An ADE was defined as any drug-related injury. They were considered preventable if they were due to an error or were preventable by any means available. A non-preventable ADE was defined as any drug-related injury in which there was no error in the medication process. A potential ADE, or near miss, was defined as a medication error with the potential to cause harm to the patient, but did not actually cause injury.

Researchers observed a 34 percent reduction for preventable ADEs, but an increase of 29.5 percent in potential ADEs or near-misses following implementation of a CPOE system.

"Our study shows that while rates of preventable ADEs may fall after CPOE implementation, all sites can benefit from tracking issues found post-implementation and making changes accordingly," Bates said. "The expertise and experience of others that have previously implemented CPOE can help guide the process."

Bates and colleagues note that further research needs to be conducted to explore the safest and most effective way to implement vendor CPOE and other technology. Bates and colleagues are currently investigating the impact of clinical decision support systems on ADE rates and identifying barriers to implementation.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis